ALX Oncology Holdings Inc. (ALXO) Misses Q1 EPS by 6c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Palo Alto Networks (PANW) call put ratio 1 call to 1.1 puts into quarter results
• Medtronic jumps on earnings beat and raised guidance